Company Information

NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE286.00-3.9 (-1.35 %)
PREV CLOSE ( ) 289.90
OPEN PRICE ( ) 287.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5566
TODAY'S LOW / HIGH ( )284.10 291.40
52 WK LOW / HIGH ( )252.4 468.25
NSE285.45-3.5 (-1.21 %)
PREV CLOSE( ) 288.95
OPEN PRICE ( ) 287.50
BID PRICE (QTY) 285.45 (9)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19786
TODAY'S LOW / HIGH( ) 283.10 291.00
52 WK LOW / HIGH ( )253.5 468.8
ChairmanSaurabh Goyal
Managing DirectorSaurabh Goyal
Company SecretaryChetna Anand
Non Executive Independent DirectorVijay Kumar Sharma
Vikram Chaudhery
Shrikant Uttam Tamhane
Charu Singh
Ruchita Agarwal
Whole Time DirectorAryan Goyal
Rajinder Sharma
Incorporation Year : 02-11 2016

Registered Office :

Address : Office No. 101, 1st Floor,Udyog Bhavan Sonawala Lane,Goregaon East Mumbai,
Maharashtra-400063 .

Phone : 0172-5292900

Email :  cs@nureca.com 

Industry : Medical Equipment/Supplies/Accessories

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.